Handelsbanken Fonder’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Hold |
34,900
| – | – | ﹤0.01% | 905 |
|
|
2025
Q1 | $1.32M | Buy |
34,900
+3,400
| +11% | +$128K | 0.01% | 826 |
|
|
2024
Q4 | $2.58M | Buy |
31,500
+4,400
| +16% | +$360K | 0.01% | 584 |
|
|
2024
Q3 | $3.1M | Sell |
27,100
-200
| -0.7% | -$22.9K | 0.01% | 528 |
|
|
2024
Q2 | $2.06M | Buy |
27,300
+7,700
| +39% | +$581K | 0.01% | 583 |
|
|
2024
Q1 | $1.34M | Hold |
19,600
| – | – | 0.01% | 727 |
|
|
2023
Q4 | $1.23M | Buy |
19,600
+6,900
| +54% | +$433K | 0.01% | 714 |
|
|
2023
Q3 | $647K | Hold |
12,700
| – | – | ﹤0.01% | 930 |
|
|
2023
Q2 | $634K | Buy |
12,700
+2,400
| +23% | +$120K | ﹤0.01% | 952 |
|
|
2023
Q1 | $386K | Hold |
10,300
| – | – | ﹤0.01% | 1140 |
|
|
2022
Q4 | $494K | Buy |
+10,300
| New | +$494K | ﹤0.01% | 966 |
|